{"organizations": [], "uuid": "f5acefe636657dc842481fb1c1efc5bbd263b145", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180124.html", "section_title": "Archive News &amp; Video for Wednesday, 24 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-faron-pharmaceuticals-says-us-fda/brief-faron-pharmaceuticals-says-u-s-fda-approved-investigational-nda-for-traumakine-idUSFWN1PJ01K", "country": "US", "domain_rank": 408, "title": "BRIEF-Faron Pharmaceuticals Says ‍U.S. FDA Approved Investigational NDA For Traumakine​", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.522, "site_type": "news", "published": "2018-01-24T15:38:00.000+02:00", "replies_count": 0, "uuid": "f5acefe636657dc842481fb1c1efc5bbd263b145"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-faron-pharmaceuticals-says-us-fda/brief-faron-pharmaceuticals-says-u-s-fda-approved-investigational-nda-for-traumakine-idUSFWN1PJ01K", "ord_in_thread": 0, "title": "BRIEF-Faron Pharmaceuticals Says ‍U.S. FDA Approved Investigational NDA For Traumakine​", "locations": [], "entities": {"persons": [{"name": "faron pharmaceuticals oy", "sentiment": "negative"}], "locations": [{"name": "us", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "brief-faron pharmaceuticals says ‍u.s. fda", "sentiment": "neutral"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 24 (Reuters) - Faron Pharmaceuticals Oy:\n* ‍US FOOD AND DRUG ADMINISTRATION HAS APPROVED INVESTIGATIONAL NEW DRUG APPLICATION FOR TRAUMAKINE​ Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 80 6749 1136)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-24T15:38:00.000+02:00", "crawled": "2018-01-25T13:04:06.000+02:00", "highlightTitle": ""}